Skip to main content

Real-time tumor tracking for magnetic resonance-guided radiotherapy using label-efficient foundation model adaptation

Journal
Physics and imaging in radiation oncology (Q1)
Published
10 September 2026
Study design
Unclassified
Evidence level
Level 5, Expert Opinion (CEBM 5)
Authors
Amparo S Betancourt Tarifa, Marcel Verheij, René Monshouwer, John J Hermans, Peter J Koopmans, Erik van der Bijl
PMID
42761505
DOI
10.1016/j.phro.2026.101078

Why clinicians should know about it

  • Picked for Medical Physics (top studies of the week, 20 September 2026): MedSAM2 adaptation enables real‑time cine‑MRI tumor tracking

Abstract

BACKGROUND AND PURPOSE: Real-time tumor tracking on cine magnetic resonance imaging (cine-MRI) enables intra-fraction motion management in magnetic resonance-guided radiotherapy. Pipelines often rely on deformable registration or template matching to propagate contours, which can degrade under non-rigid motion and cine-MRI artifacts. This study evaluated two MedSAM2-based adaptations for real-time tracking with limited labels. MATERIALS AND METHODS: The TrackRAD2025 dataset includes sagittal cine-MRI sequences from six institutions acquired on 0.35 T and 1.5 T MRI-linear accelerators, with 50 labeled and 477 unlabeled training cases and 50 test cases. Tracking was formulated as frame-wise target segmentation from the first-frame ground-truth mask. Method A fine-tuned MedSAM2 on 40 labeled cases and used rank-weighted checkpoint averaging. Method B combined two MedSAM2 models trained on different labeled splits augmented with pseudo-labels, and merged their predictions during inference. RESULTS: On the hidden test set, Method A ranked highest on Dice similarity coefficient (DSC), center distance (CD), 95th-percentile Hausdorff distance (HD95), and mean average surface distance (MASD), with DSC = 0.891, CD = 1.47 mm, HD95 = 4.22 mm, MASD = 1.66 mm, relative dose to 98% of the target volume ( D 98 % ) = 0.936, and runtime of 0.04 s per frame. Method B achieved similar geometric performance and numerically higher relative D 98 % (0.953), at 0.10 s per frame. Paired Wilcoxon signed-rank testing showed no significant differences after correction for multiple testing. CONCLUSIONS: MedSAM2 adaptation enabled real-time cine-MRI tumor tracking with limited labels. The single-model approach provided faster inference and simpler deployment, while semi-supervised ensembling showed no significant improvement at higher computational cost.

Abstract as published, via PubMed.

View on PubMedFull text at the publisherOpen in the app

For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.